Brainstorm Cell Therapeutics - 48 Year Dividend Yield History | BCLI

Historical dividend payout and yield for Brainstorm Cell Therapeutics (BCLI) since 1971. The current TTM dividend payout for Brainstorm Cell Therapeutics (BCLI) as of February 20, 2019 is $0.00. The current dividend yield for Brainstorm Cell Therapeutics as of February 20, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.082B $0.000B
BrainStorm Cell Therapeutics Inc. is a biotechnology company. It develops autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis, Multiple Sclerosis and Parkinson's disease. Brainstorm Cell Therapeutics is based in New York.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.347B 12.98
Gilead Sciences (GILD) United States $86.362B 10.84
Bio-Techne Corp (TECH) United States $7.246B 48.82